Literature DB >> 26607256

Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin.

David Weinshenker1, Philip V Holmes2.   

Abstract

Decades of research confirm that noradrenergic locus coeruleus (LC) neurons are essential for arousal, attention, motivation, and stress responses. While most studies on LC transmission focused unsurprisingly on norepinephrine (NE), adrenergic signaling cannot account for all the consequences of LC activation. Galanin coexists with NE in the vast majority of LC neurons, yet the precise function of this neuropeptide has proved to be surprisingly elusive given our solid understanding of the LC system. To elucidate the contribution of galanin to LC physiology, here we briefly summarize the nature of stimuli that drive LC activity from a neuroanatomical perspective. We go on to describe the LC pathways in which galanin most likely exerts its effects on behavior, with a focus on addiction, depression, epilepsy, stress, and Alzheimer׳s disease. We propose a model in which LC-derived galanin has two distinct functions: as a neuromodulator, primarily acting via the galanin 1 receptor (GAL1), and as a trophic factor, primarily acting via galanin receptor 2 (GAL2). Finally, we discuss how the recent advances in neuropeptide detection, optogenetics and chemical genetics, and galanin receptor pharmacology can be harnessed to identify the roles of LC-derived galanin definitively. This article is part of a Special Issue entitled SI: Noradrenergic System.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addiction; Alzheimer׳s disease; Depression; Epilepsy; Galanin; Locus coeruleus; Norepinephrine; Stress

Mesh:

Substances:

Year:  2015        PMID: 26607256      PMCID: PMC4874918          DOI: 10.1016/j.brainres.2015.11.025

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  236 in total

1.  Galanin-like immunoreactivity in hippocampal afferents in the rat, with special reference to cholinergic and noradrenergic inputs.

Authors:  T Melander; W A Staines; A Rökaeus
Journal:  Neuroscience       Date:  1986-09       Impact factor: 3.590

2.  Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access.

Authors:  Sunmee Wee; Chitra D Mandyam; Dusan M Lekic; George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-24       Impact factor: 4.600

Review 3.  Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors.

Authors:  Andrey Mazarati; Xiaoying Lu
Journal:  Neuropeptides       Date:  2005-01-28       Impact factor: 3.286

4.  Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice.

Authors:  Rose-Marie Karlsson; Andrew Holmes; Markus Heilig; Jacqueline N Crawley
Journal:  Pharmacol Biochem Behav       Date:  2005-01-25       Impact factor: 3.533

5.  Evidence for corticotropin-releasing hormone projections from Barrington's nucleus to the periaqueductal gray and dorsal motor nucleus of the vagus in the rat.

Authors:  R J Valentino; L A Pavcovich; H Hirata
Journal:  J Comp Neurol       Date:  1995-12-18       Impact factor: 3.215

Review 6.  The role of norepinephrine in epilepsy: from the bench to the bedside.

Authors:  Filippo S Giorgi; Chiara Pizzanelli; Francesca Biagioni; Luigi Murri; Francesco Fornai
Journal:  Neurosci Biobehav Rev       Date:  2004-09       Impact factor: 8.989

Review 7.  Galanin overexpressing transgenic mice.

Authors:  Jacqueline N Crawley; Elliott J Mufson; John G Hohmann; Dawit Teklemichael; Robert A Steiner; Kristina Holmberg; Zhi-Qing D Xu; Karin Hygge Blakeman; Xiao-Jun Xu; Zsuzsanna Wiesenfeld-Hallin; Tamas Bartfai; Tomas Hökfelt
Journal:  Neuropeptides       Date:  2002 Apr-Jun       Impact factor: 3.286

8.  Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS.

Authors:  T Melander; T Hökfelt; A Rökaeus; A C Cuello; W H Oertel; A Verhofstad; M Goldstein
Journal:  J Neurosci       Date:  1986-12       Impact factor: 6.167

9.  Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2.

Authors:  Caroline R Elliott-Hunt; Fiona E Holmes; Dean M Hartley; Sylvia Perez; Elliott J Mufson; David Wynick
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

10.  GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP-dependent mechanism.

Authors:  Jessica J Hawes; Darlene H Brunzell; David Wynick; Venetia Zachariou; Marina R Picciotto
Journal:  J Neurochem       Date:  2005-06       Impact factor: 5.372

View more
  16 in total

1.  Comparison of the VTA and LC response to methylphenidate: a concomitant behavioral and neuronal study of adolescent male rats.

Authors:  Tahseen J Karim; Cruz Reyes-Vazquez; Nachum Dafny
Journal:  J Neurophysiol       Date:  2017-06-14       Impact factor: 2.714

2.  Fronto-temporal galanin modulates impulse control.

Authors:  F Messanvi; A Perkins; J du Hoffmann; Y Chudasama
Journal:  Psychopharmacology (Berl)       Date:  2019-11-08       Impact factor: 4.530

3.  Associations between MRI-assessed locus coeruleus integrity and cortical gray matter microstructure.

Authors:  Jeremy A Elman; Olivia K Puckett; Donald J Hagler; Rahul C Pearce; Christine Fennema-Notestine; Sean N Hatton; Michael J Lyons; Linda K McEvoy; Matthew S Panizzon; Emilie T Reas; Anders M Dale; Carol E Franz; William S Kremen
Journal:  Cereb Cortex       Date:  2022-09-19       Impact factor: 4.861

Review 4.  Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease.

Authors:  David Weinshenker
Journal:  Trends Neurosci       Date:  2018-02-20       Impact factor: 13.837

5.  Co-released norepinephrine and galanin act on different timescales to promote stress-induced anxiety-like behavior.

Authors:  Rachel P Tillage; Stephanie L Foster; Daniel Lustberg; L Cameron Liles; Katharine E McCann; David Weinshenker
Journal:  Neuropsychopharmacology       Date:  2021-04-28       Impact factor: 8.294

Review 6.  Preclinical evidence of ghrelin as a therapeutic target in epilepsy.

Authors:  Tongtong Ge; Wei Yang; Jie Fan; Bingjin Li
Journal:  Oncotarget       Date:  2017-06-02

Review 7.  Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus.

Authors:  Termpanit Chalermpalanupap; David Weinshenker; Jacki M Rorabaugh
Journal:  Neural Plast       Date:  2017-09-05       Impact factor: 3.599

8.  Elimination of galanin synthesis in noradrenergic neurons reduces galanin in select brain areas and promotes active coping behaviors.

Authors:  Rachel P Tillage; Natale R Sciolino; Nicholas W Plummer; Daniel Lustberg; L Cameron Liles; Madeline Hsiang; Jeanne M Powell; Kathleen G Smith; Patricia Jensen; David Weinshenker
Journal:  Brain Struct Funct       Date:  2020-02-17       Impact factor: 3.270

9.  Chronic Environmental or Genetic Elevation of Galanin in Noradrenergic Neurons Confers Stress Resilience in Mice.

Authors:  Rachel P Tillage; Genevieve E Wilson; L Cameron Liles; Philip V Holmes; David Weinshenker
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

10.  Involvement of Scratch2 in GalR1-mediated depression-like behaviors in the rat ventral periaqueductal gray.

Authors:  Yutao Yang; Yueting Li; Bo Liu; Chenchen Li; Zijin Liu; Jiahui Deng; Hanjiang Luo; Xiaoxiao Li; Jinjin Wu; Hui Li; Chuan-Yue Wang; Ming Zhao; Haohao Wu; Francois Lallemend; Per Svenningsson; Tomas G M Hökfelt; Zhi-Qing David Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.